W2O Group chief Jim Weiss continues his firm’s acquisition binge by adding Swoop and IPM.ai data-driven technology firms to its line-up.
Swoop and IPM.ai uses machine learning, artificial intelligence and real-world data to solve healthcare challenges.
Swoop creates precise patient audiences, improves targeting of services and empowers people to take active roles in their treatments, while IPM.ai uncovers ideal patients to accelerate R&D and commercialization of therapies.
The addition of the firms will “help our clients move faster and with more precision and efficiency to conduct clinical trials, launch new products, maximize peak revenue opportunities and successfully negate product lifecycles,” said Weiss.
W2O has created a health technology business unit to house Swoop, IPM.ai, Symplur and data/analytics software assets under Adam Cossman, group VP and HTB managing partner.
The San Franciso-based firm has made nine acquisitions since it unveiled its partnership with New Mountain Capital in 2019.
It is O’Dwyer’s top-ranked healthcare firm with 2019 fees of $218.9M.